ROPIVACAINE HCL

Ropivacaine HCl offers enhanced solubility and identical anesthetic properties for epidural and regional blocks. Side effects include nausea, dizziness, hypotension, and, at high doses, CNS or cardiovascular toxicity. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 72031f855a5b Category: Tag:

Product Description


Mechanism of Action

ROPIVACAINE HCL displays a multidimensional biochemical activity profile integrating modulation of enzymatic pathways, receptormediated signalling, mitochondrial bioenergetics, oxidativestress homeostasis, ionchannel dynamics, membrane structural behaviour and transcriptionfactor regulation. Structural modelling suggests interactions with catalytic residues, allosteric microdomains, transmembrane helices, signalling cofactors and cytoskeletal complexes. These interactions enable influence over phosphorylation cascades, secondmessenger flux (Ca²⁺, IP, DAG, cAMP), ROS balance, ATP turnover, membranepotential stability and organelle stressresponse thresholds.

Benefits and Applications

  • Receptorligand affinity analysis and docking studies
  • Enzymekinetic profiling and catalyticflux pathway mapping
  • Mitochondrialfunction modelling and ATP/ROS system evaluation
  • Transcriptomic, metabolomic, proteomic and phosphoproteomic profiling
  • Cytoskeletalarchitecture and membranedynamics exploration
  • Apoptosis, autophagy, necroptosis and ferroptosis pathway modelling
  • SAR/QSAR modelling and compoundoptimisation workflows
  • Mechanistic pharmacodynamics and doseresponse simulation

Side Effects and Risks

  • Oxidativestress imbalance and elevated ROS
  • Mitochondrial overload or respiratorychain suppression
  • Disruption of Ca²⁺/Na⁺/K⁺ ionhomeostasis
  • Unintended receptor crosstalk or inhibitory signal interference
  • Cytoskeletal destabilisation and membrane-integrity reduction
  • Dosedependent cytotoxicity or programmed-cell-death activation
  • Transcriptional and epigenetic instability
  • Inflammatorycascade activation (NF-κB, MAPK, JNK)

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C17H26N2O·HCl

Molecular Weight

310.9 g/mol

CAS Number

98717-15-8

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Ropivacaine hydrochloride; ROPIVACAINE HCl; 98717-15-8; Ropivacaine monohydrochloride; ROPIVACAINE HYDROCHLORIDE MONOHYDRATE

IUPAC/Chemical Name

(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide;hydrochloride

InChl Key

NDNSIBYYUOEUSV-RSAXXLAASA-N

InChl Code

InChI=1S/C17H26N2O.ClH/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3;/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20);1H/t15-;/m0./s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/175804;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download